OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Early investment in formulation strategies will maximize the chance of success.
Advances in simulation and the development of digital twins.
Different methods give different answers when calculating limits for impurities.
Automatic visual inspection machines and AI highlight inspection deficits.
Despite their promise, alternative drug delivery approaches are complex and must be justified.
Traditional statistical process control rules can be relaxed or adjusted to allow charting and evaluation of real-life data.
Novavax COVID-19 Vaccine Receives EUA in Indonesia
December 06, 2021
Recordati’s blockbuster acquisition of EUSA Pharma gives them access to a portfolio of four drugs that treat rare cancers.
Following mixed results from clinical trials, a panel of outside experts voted 13-10 to recommend Merck’s pill for Emergency Use Authorization.
December 03, 2021
Subtitle FDA approved rituximab in combination with chemotherapy for pediatric patients with previously untreated, advanced stage, CD20-positive DLBCL/BL/BLL/B-AL.
The companies will focus on the rapid development of polymerase chain reaction assays for emerging pathogens and potential health threats, including biological threats.
Fujifilm’s center adds local support in Suzhou, China for cell culture media optimization.
This collaboration aims to better understand Alzheimer’s and Parkinson’s disease and increase drug discovery and development success rates.
Moderna’s agreement with the UK government includes 29 million COVID-19 vaccine doses for delivery in 2022 and 31 million doses for delivery in 2023.
High price tags threaten to block patient access to potentially life-saving cures and treatments.
Bio/pharmaceutical manufacturing harnesses the benefits of digital transformation.
Polpharma implemented digital technologies, including a digital twin of operations.